Dr. Jerry Vockley Elected to the Association of American Physicians
Recent INFORM Advances and Accomplishments [...]
Recent INFORM Advances and Accomplishments
Recent INFORM Advances and Accomplishments [...]
Vockley, et al., Published In JCI Insight
Vockley, et al., Published In JCI Insight [...]
Vockley Appointed To FDA Advisory Council
Vockley Appointed To FDA Advisory Council [...]
Early diagnosis and treatment by newborn screening (NBS) or family history is associated with improved visual outcomes for long-chain 3-hydroxyacylCoA dehydrogenase deficiency (LCHADD) chorioretinopathy GalleryEarly diagnosis and treatment by newborn screening (NBS) or family history is associated with improved visual outcomes for long-chain 3-hydroxyacylCoA dehydrogenase deficiency (LCHADD) chorioretinopathy
Early diagnosis and treatment by newborn screening (NBS) or family history is associated with improved visual outcomes for long-chain 3-hydroxyacylCoA dehydrogenase deficiency (LCHADD) chorioretinopathy
Early diagnosis and treatment by newborn screening (NBS) or [...]
INFORM 2023 Bringing the Latest in Fatty Acid Oxidation Disorders Research to Israel
INFORM 2023 Bringing the Latest in Fatty Acid Oxidation [...]
Hypoketotic Hypoglycemia Explained in Simple Terms
Hypoketotic Hypoglycemia Explained in Simple Terms [...]
Ultragenyx Announces U.S. FDA Approval of Dojolvi™ (UX007/triheptanoin), the First FDA-Approved Therapy for the Treatment of Long-chain Fatty Acid Oxidation Disorders GalleryUltragenyx Announces U.S. FDA Approval of Dojolvi™ (UX007/triheptanoin), the First FDA-Approved Therapy for the Treatment of Long-chain Fatty Acid Oxidation Disorders
Ultragenyx Announces U.S. FDA Approval of Dojolvi™ (UX007/triheptanoin), the First FDA-Approved Therapy for the Treatment of Long-chain Fatty Acid Oxidation Disorders
Ultragenyx Announces U.S. FDA Approval of Dojolvi™ (UX007/triheptanoin), the [...]
INFORM Conference Explores Future of Disorders of Fatty Acid Oxidation
INFORM Conference Explores Future of Disorders of Fatty Acid [...]
Unlocking the Future
We are committed to discovering new FAOD treatments and cures to improve the lives of our patients and their families.
